29 Unraveling molecular drivers of brain cancers at the clinical setting by Wong, D., Shen, Y., Levine, A. B., Hoon Lee, T., Pleasance, E., Jones, M., Thiessen, B., Toyota, B., Laskin, C.M, J., Jones, S., Marra, M. A, Yip, S.

Get full text

9170 Safety and efficacy of first-line bevacizumab (Bv) plus chemotherapy in elderly patients (pts) with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): SAiL... by Garrido, P, Thatcher, N, Crino, L, Dansin, E, Laskin, J, Pavlakis, N, Tsai, C.M, Reck, M, Schneider, C.P, Griesinger, F

Get full text

9168 Safety and efficacy of first-line bevacizumab-based therapy in advanced non-small cell lung cancer (NSCLC): results of the SAiL study (MO19390) by Dansin, E, Tsai, C.M, Pavlakis, N, Laskin, J, Griesinger, F, Garrido, P, Crino, L, Wu, Y.L, Jiang, G.L, Thatcher, N

Get full text

6594 POSTER First-line bevacizumab in combination with chemotherapy in the treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): an open... by Crinó, L, Dansin, E, Garrido Lopez, P, Griesinger, F, Laskin, J, Pavlakis, N, Thatcher, N, Tsai, C.M, Stroyakovskiy, D, Su, W.C

Get full text

American Judaism's future by Walk, Garry, Fletcher, C.M, Freeman, Tzvi, Biren, Curt, Birnbaum, Norman, Peterson, Michael, Stambler, Elliot J, Goldberg, Steve, Lubicz, Stephane, Gordon, Dana, Spero, Shubert, Rhoads, Patrick, Kalet, Yitzhak Irving, Cohn, John R, Laskin, Martin, Epstein, Lawrence J

Get full text